Chao Wu

Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations.

G. Liang, Weitao Fu, Lingfeng Chen, 2017, Physical chemistry chemical physics : PCCP.

Insight into ponatinib resistance mechanisms in rhabdomyosarcoma caused by the mutations in FGFR4 tyrosine kinase using molecular modeling strategies.

Fuchuan Li, Yuepiao Cai, Zhiguo Liu, 2019, International journal of biological macromolecules.

Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury.

G. Liang, Lingfeng Chen, Chenglong Li, 2019, Journal of medicinal chemistry.

Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells

G. Liang, Huiping Zhou, Yuepiao Cai, 2018, Redox biology.

Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury.

G. Liang, Lingfeng Chen, Lulu Zheng, 2019, European journal of medicinal chemistry.

Synthesis, biological evaluation, and molecular docking study of novel allyl-retrochalcones as a new class of protein tyrosine phosphatase 1B inhibitors.

Ying Su, Suqing Zheng, Weiwei Zhu, 2019, Bioorganic & medicinal chemistry.